Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Applying to Tucson Clinical Research Institute- Site Number : 8400006 · Tucson, Arizona
Answer a few short questions to share with the research team.